×

Pfizer, J&J Halt Alzheimer's Drug Trials

10:12 AM ET Tue, 7 Aug 2012

CNBC's Seema Mody reports Pfizer and Johnson & Johnson are scrapping their phase three studies of Alzheimer's drug known as "Bapi" after it failed to slow memory loss.